During the last session, Q32 Bio Inc (NASDAQ:QTTB)’s traded shares were 0.11 million, with the beta value of the company hitting -0.10. At the end of the trading day, the stock’s price was $2.12, reflecting an intraday gain of 14.59% or $0.27. The 52-week high for the QTTB share is $53.79, that puts it down -2437.26 from that peak though still a striking 34.91% gain since the share price plummeted to a 52-week low of $1.38. The company’s market capitalization is $25.86M, and the average intraday trading volume over the past 10 days was 0.2 million shares, and the average trade volume was 204.41K shares over the past three months.
Q32 Bio Inc (QTTB) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.33. QTTB has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.
Q32 Bio Inc (NASDAQ:QTTB) trade information
Q32 Bio Inc (QTTB) registered a 14.59% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 14.59% in intraday trading to $2.12, hitting a weekly high. The stock’s 5-day price performance is 26.19%, and it has moved by -1.85% in 30 days. Based on these gigs, the overall price performance for the year is -91.52%. The short interest in Q32 Bio Inc (NASDAQ:QTTB) is 0.87 million shares and it means that shorts have 4.37 day(s) to cover.
The consensus price target of analysts on Wall Street is $64, which implies an increase of 96.69% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $64 and $64 respectively. As a result, QTTB is trading at a discount of -2918.87% off the target high and -2918.87% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 31.75%. While earnings are projected to return 36.17% in 2025, the next five years will return 6.39% per annum.
QTTB Dividends
Q32 Bio Inc is due to release its next quarterly earnings on 2025-Mar-10. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Q32 Bio Inc (NASDAQ:QTTB)’s Major holders
Q32 Bio Inc insiders own 8.70% of total outstanding shares while institutional holders control 79.82%, with the float percentage being 87.43%. ORBIMED ADVISORS LLC is the largest shareholder of the company, while 115.0 institutions own stock in it. As of 2024-06-30, the company held over 2.25 million shares (or 18.831% of all shares), a total value of $40.44 million in shares.
The next largest institutional holding, with 2.09 million shares, is of ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC’s that is approximately 17.4863% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $37.55 million.
